Published in Neuropsychiatr Dis Treat on April 12, 2017
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63
Schizophrenia. Lancet (2009) 8.14
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A (1997) 6.99
A systematic review of the prevalence of schizophrenia. PLoS Med (2005) 6.99
Synaptic scaling mediated by glial TNF-alpha. Nature (2006) 6.76
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71
Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res (1985) 5.22
Genetic influence on cytokine production and fatal meningococcal disease. Lancet (1997) 4.89
Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev (2008) 4.43
HLA and disease 1982--a survey. Immunol Rev (1983) 3.87
Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry (2000) 2.96
Cytokines and CNS development. Neuron (2009) 2.15
Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol (1999) 1.87
Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry (2001) 1.78
Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry (2005) 1.76
The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry (2006) 1.64
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res (2008) 1.29
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res (2007) 1.25
Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front Synaptic Neurosci (2010) 1.25
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med Hypotheses (2001) 1.13
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett (1996) 1.11
The catecholamine cytokine balance: interaction between the brain and the immune system. Ann N Y Acad Sci (2007) 1.04
Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry (1998) 0.99
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur Neuropsychopharmacol (2000) 0.98
Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany. Dermatology (1993) 0.98
Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol (2007) 0.97
Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology (2012) 0.95
Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis. Psychiatry Res (2010) 0.95
Association study of IL10, IL1beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1beta. Schizophr Res (2006) 0.93
Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J Biol Psychiatry (2000) 0.92
Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. J Psychiatr Res (2013) 0.90
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: meta-analysis plus association study. Brain Behav Immun (2007) 0.88
Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo. Genet Mol Res (2013) 0.87
TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients. Clin Med Insights Arthritis Musculoskelet Disord (2011) 0.86
Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls. Psychiatr Danub (2012) 0.82
Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population. Neuropsychobiology (2008) 0.81
Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition. Psychopharmacology (Berl) (2014) 0.81
Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia. Schizophr Res (2003) 0.81
Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNFα) gene polymorphisms with paranoid schizophrenia in a Polish population. J Neuropsychiatry Clin Neurosci (2013) 0.81
Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication. Psychopharmacology (Berl) (2006) 0.81
TNFB polymorphism may be associated with schizophrenia in the Korean population. Schizophr Res (2003) 0.80
Association analysis of the -308G>A promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia. J Neural Transm (Vienna) (2004) 0.79
No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine. Schizophr Res (2003) 0.79
Tumor necrosis factor-alpha gene promoter polymorphisms in chronic schizophrenia. Biol Psychiatry (2003) 0.79
Potential role of lymphotoxin-alpha (tumor necrosis factor-beta) in the development of schizophrenia. Med Hypotheses (2006) 0.79
Analysis of a polymorphism in the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia. Mol Psychiatry (2003) 0.78
No association between the tumor necrosis factor-alpha gene promoter polymorphisms and schizophrenia in a Japanese population. Psychiatry Res (2007) 0.78
Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2007) 0.78
Tumor necrosis factor-alpha gene polymorphism at position -308 and schizophrenia in the Korean population. Psychiatry Clin Neurosci (2003) 0.78
Is there an immunologic basis for schizophrenia? Expert Rev Clin Immunol (2005) 0.78
Tumor necrosis factor haplotype analysis amongst schizophrenia probands from four distinct populations in the Asia-Pacific region. Am J Med Genet B Neuropsychiatr Genet (2003) 0.78
Tumor necrosis factor-alpha --G308A polymorphism in schizophrenia in a Finnish population. Neurosci Lett (2005) 0.78
Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.78
Association between ANKK1 (rs1800497) and LTA (rs909253) Genetic Variants and Risk of Schizophrenia. Biomed Res Int (2015) 0.78
HLA-DRB1 association with schizophrenia in Saudi Arabian patients. Int J Psychiatry Clin Pract (2010) 0.77
Elevated serum levels of TNF-α, IL-6 and IL-18 in chronic schizophrenic patients. Schizophr Res (2014) 0.77
Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia. J Neuroinflammation (2016) 0.77
No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia. Eur Arch Psychiatry Clin Neurosci (2002) 0.77
Meta-Analysis of Cytokine and Chemokine Genes in Schizophrenia. Clin Schizophr Relat Psychoses (2016) 0.77
Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine. Iran J Immunol (2014) 0.77
Potential role of Neuregulin 1 and TNF-alpha (-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan. Mol Biol Rep (2010) 0.77
Association between CMYA5 gene polymorphisms and risk of schizophrenia in Uygur population and a meta-analysis. Early Interv Psychiatry (2015) 0.76
Genetic association of catechol-O-methyltransferase val(158)met polymorphism in Saudi schizophrenia patients. Genet Mol Res (2014) 0.76
No association between the promoter variants of tumor necrosis factor alpha (TNF-alpha) and schizophrenia in Chinese Han population. Neurosci Lett (2004) 0.76
Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci (2004) 0.76